O-GlcNAcylation and cancer / / Ikram El Yazidi-Belkoura, Tony Lefebvre, (editors).
his book gathers reviews and articles on the role of O-GlcNAcylation in cancer underlying the pharmacological targeting of the O-GlcNAcylation enzymes OGT and OGA as a promising anticancer strategy. Particular attention is paid to the involvement of O-GlcNAcylation in the regulation of transcription...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, [2022] ©2022 |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (112 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993603211604498 |
---|---|
ctrlnum |
(CKB)5400000000043089 (NjHacI)995400000000043089 (EXLCZ)995400000000043089 |
collection |
bib_alma |
record_format |
marc |
spelling |
O-GlcNAcylation and cancer / Ikram El Yazidi-Belkoura, Tony Lefebvre, (editors). Basel : MDPI - Multidisciplinary Digital Publishing Institute, [2022] ©2022 1 online resource (112 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on print version record. his book gathers reviews and articles on the role of O-GlcNAcylation in cancer underlying the pharmacological targeting of the O-GlcNAcylation enzymes OGT and OGA as a promising anticancer strategy. Particular attention is paid to the involvement of O-GlcNAcylation in the regulation of transcription and as a link between nutrition and epigenetic dynamics or cellular energy metabolism. The role of O-GlcNAcylation in metastasis, immune responses, and resistance to chemotherapeutic agents is also discussed. 1. Introduction -- 2. O-GlcNAcylation -- 2.2. Functions of O-GlcNAcylation -- 3. O-GlcNAcylation and Cancer -- 3.1. O-GlcNAcylation and Metastasis -- 3.2. O-GlcNAcylation and Receptor Tyrosine Kinase -- 3.3. O-GlcNAcylation and Resistance to Chemotherapy -- 3.4. O-GlcNAcylation as Prognostic Marker -- 4. O-GlcNAcylation and Immune Responses in Cancer -- 4.1. Overview of Immune System and O-GlcNAcylation -- 4.2. T Cell Activation and Differentiation Regulated by O-GlcNAcylation -- 4.3. Macrophage Differentiation and Activation by O-GlcNAcylation -- 4.4. O-GlcNAcylation and Tumor Microenvironment -- 5. Cancer Therapeutics Targeting O-GlcNAcylation -- 6. Conclusions and Future Perspectives -- Author Contributions -- Funding -- Conflicts of Interest -- Footnotes -- References. Glycosylation. 3-0365-3083-5 Lefebvre, Tony , editor. El Yazidi-Belkoura, Ikram, editor. |
language |
English |
format |
eBook |
author2 |
Lefebvre, Tony , El Yazidi-Belkoura, Ikram, |
author_facet |
Lefebvre, Tony , El Yazidi-Belkoura, Ikram, |
author2_variant |
t l tl y b i e ybi ybie |
author2_role |
TeilnehmendeR TeilnehmendeR |
title |
O-GlcNAcylation and cancer / |
spellingShingle |
O-GlcNAcylation and cancer / 1. Introduction -- 2. O-GlcNAcylation -- 2.2. Functions of O-GlcNAcylation -- 3. O-GlcNAcylation and Cancer -- 3.1. O-GlcNAcylation and Metastasis -- 3.2. O-GlcNAcylation and Receptor Tyrosine Kinase -- 3.3. O-GlcNAcylation and Resistance to Chemotherapy -- 3.4. O-GlcNAcylation as Prognostic Marker -- 4. O-GlcNAcylation and Immune Responses in Cancer -- 4.1. Overview of Immune System and O-GlcNAcylation -- 4.2. T Cell Activation and Differentiation Regulated by O-GlcNAcylation -- 4.3. Macrophage Differentiation and Activation by O-GlcNAcylation -- 4.4. O-GlcNAcylation and Tumor Microenvironment -- 5. Cancer Therapeutics Targeting O-GlcNAcylation -- 6. Conclusions and Future Perspectives -- Author Contributions -- Funding -- Conflicts of Interest -- Footnotes -- References. |
title_full |
O-GlcNAcylation and cancer / Ikram El Yazidi-Belkoura, Tony Lefebvre, (editors). |
title_fullStr |
O-GlcNAcylation and cancer / Ikram El Yazidi-Belkoura, Tony Lefebvre, (editors). |
title_full_unstemmed |
O-GlcNAcylation and cancer / Ikram El Yazidi-Belkoura, Tony Lefebvre, (editors). |
title_auth |
O-GlcNAcylation and cancer / |
title_new |
O-GlcNAcylation and cancer / |
title_sort |
o-glcnacylation and cancer / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2022 |
physical |
1 online resource (112 pages) |
contents |
1. Introduction -- 2. O-GlcNAcylation -- 2.2. Functions of O-GlcNAcylation -- 3. O-GlcNAcylation and Cancer -- 3.1. O-GlcNAcylation and Metastasis -- 3.2. O-GlcNAcylation and Receptor Tyrosine Kinase -- 3.3. O-GlcNAcylation and Resistance to Chemotherapy -- 3.4. O-GlcNAcylation as Prognostic Marker -- 4. O-GlcNAcylation and Immune Responses in Cancer -- 4.1. Overview of Immune System and O-GlcNAcylation -- 4.2. T Cell Activation and Differentiation Regulated by O-GlcNAcylation -- 4.3. Macrophage Differentiation and Activation by O-GlcNAcylation -- 4.4. O-GlcNAcylation and Tumor Microenvironment -- 5. Cancer Therapeutics Targeting O-GlcNAcylation -- 6. Conclusions and Future Perspectives -- Author Contributions -- Funding -- Conflicts of Interest -- Footnotes -- References. |
isbn |
3-0365-3083-5 |
callnumber-first |
Q - Science |
callnumber-subject |
QP - Physiology |
callnumber-label |
QP552 |
callnumber-sort |
QP 3552 G59 O45 42022 |
illustrated |
Not Illustrated |
dewey-hundreds |
500 - Science |
dewey-tens |
570 - Life sciences; biology |
dewey-ones |
572 - Biochemistry |
dewey-full |
572.68 |
dewey-sort |
3572.68 |
dewey-raw |
572.68 |
dewey-search |
572.68 |
work_keys_str_mv |
AT lefebvretony oglcnacylationandcancer AT elyazidibelkouraikram oglcnacylationandcancer |
status_str |
n |
ids_txt_mv |
(CKB)5400000000043089 (NjHacI)995400000000043089 (EXLCZ)995400000000043089 |
carrierType_str_mv |
cr |
is_hierarchy_title |
O-GlcNAcylation and cancer / |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796653209060638722 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02278nam a2200313 i 4500</leader><controlfield tag="001">993603211604498</controlfield><controlfield tag="005">20230624091530.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230624s2022 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043089</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000043089</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043089</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP552.G59</subfield><subfield code="b">.O45 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">572.68</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">O-GlcNAcylation and cancer /</subfield><subfield code="c">Ikram El Yazidi-Belkoura, Tony Lefebvre, (editors).</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (112 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">his book gathers reviews and articles on the role of O-GlcNAcylation in cancer underlying the pharmacological targeting of the O-GlcNAcylation enzymes OGT and OGA as a promising anticancer strategy. Particular attention is paid to the involvement of O-GlcNAcylation in the regulation of transcription and as a link between nutrition and epigenetic dynamics or cellular energy metabolism. The role of O-GlcNAcylation in metastasis, immune responses, and resistance to chemotherapeutic agents is also discussed.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Introduction -- 2. O-GlcNAcylation -- 2.2. Functions of O-GlcNAcylation -- 3. O-GlcNAcylation and Cancer -- 3.1. O-GlcNAcylation and Metastasis -- 3.2. O-GlcNAcylation and Receptor Tyrosine Kinase -- 3.3. O-GlcNAcylation and Resistance to Chemotherapy -- 3.4. O-GlcNAcylation as Prognostic Marker -- 4. O-GlcNAcylation and Immune Responses in Cancer -- 4.1. Overview of Immune System and O-GlcNAcylation -- 4.2. T Cell Activation and Differentiation Regulated by O-GlcNAcylation -- 4.3. Macrophage Differentiation and Activation by O-GlcNAcylation -- 4.4. O-GlcNAcylation and Tumor Microenvironment -- 5. Cancer Therapeutics Targeting O-GlcNAcylation -- 6. Conclusions and Future Perspectives -- Author Contributions -- Funding -- Conflicts of Interest -- Footnotes -- References.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Glycosylation.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3083-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lefebvre, Tony ,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">El Yazidi-Belkoura, Ikram,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-06 03:06:55 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337923530004498&Force_direct=true</subfield><subfield code="Z">5337923530004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337923530004498</subfield></datafield></record></collection> |